Legal & General Group PLC Dice Therapeutics, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $361,083 - $652,211	13,963 Added 88.51%	29,738 $1.38 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $37,433 - $46,429	1,437 Added 10.02%	15,775 $451,000
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $182,991 - $390,880	9,256 Added 182.13%	14,338 $447,000
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $4,760 - $7,202	318 Added 6.68%	5,082 $104,000
Q2 2022 Aug 22, 2022	BUY	$13.19 - $22.1 $45,624 - $76,443	3,459 Added 265.06%	4,764 $74,000
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $218 - $375	15 Added 1.16%	1,305 $25,000
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $28,908 - $48,426	1,290 New	1,290 $33,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.